Literature DB >> 18078237

Peripheral nerve injury induced expression of mRNA for serine protease inhibitor 3 in the rat facial and hypoglossal nuclei but not in the spinal cord.

A P Gesase1, H Kiyama.   

Abstract

The current work has documented the expression of the mRNAs for serine protease inhibitor 3 (SPI-3) in the facial and hypoglossal nuclei following peripheral nerve transection by using the in situ hybridization method. The signals appeared 6 hour after nerve injury; they became stronger on day 1 of injury and persisted for 21 days. SPI-3 may be involved during early events of modulating the activities of serine proteases following nerve injury. Such activities may include synaptic stripping and re-organization and facilitation of glial cell reaction to nerve injury. In the later stages of nerve injury SPI-3 may enhance neuronal survival, growth of neurites and re-establishment of synaptic contacts in the facial and hypoglossal nuclei. Hypoglossal but not facial nerve transection caused the expression of mRNAs for SPI-3 in the pineal gland. The signals appeared 6 hours after nerve injury and persisted for 21 days. The significance of this observation is not known but it indicates that the pineal gland senses injury to some peripheral nerves including the hypoglossal nerve. The study has also showed that axotomy of the sciatic nerve did not give rise to the up-regulation of the mRNAs for SPI-3 in the spinal cord. There was no hybridization signals in the lumbar segments; an indication that SPI-3 may not form part of molecules that are released during sciatic nerve transaction by the neural and non-neural cells of the spinal cord. At the moment there are no antibodies for SPI-3 and therefore future studies are needed to verify the findings. It will be interesting also to study on the role of pineal gland during peripheral nerve injuries.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18078237

Source DB:  PubMed          Journal:  Ital J Anat Embryol        ISSN: 1122-6714


  6 in total

1.  Genomic analysis of reactive astrogliosis.

Authors:  Jennifer L Zamanian; Lijun Xu; Lynette C Foo; Navid Nouri; Lu Zhou; Rona G Giffard; Ben A Barres
Journal:  J Neurosci       Date:  2012-05-02       Impact factor: 6.167

2.  CSF SERPINA3 Levels Are Elevated in Patients With Progressive MS.

Authors:  Nicolás Fissolo; Clara Matute-Blanch; Mohamoud Osman; Carme Costa; Rucsanda Pinteac; Berta Miró; Alex Sanchez; Verónica Brito; Irena Dujmovic; Margarete Voortman; Michael Khalil; Eva Borràs; Eduard Sabidó; Shohreh Issazadeh-Navikas; Xavier Montalban; Manuel Comabella Lopez
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-01-12

3.  Identification of PCSK9 as a novel serum biomarker for the prenatal diagnosis of neural tube defects using iTRAQ quantitative proteomics.

Authors:  Dong An; Xiaowei Wei; Hui Li; Hui Gu; Tianchu Huang; Guifeng Zhao; Bo Liu; Weilin Wang; Lizhu Chen; Wei Ma; Henan Zhang; Songying Cao; Zhengwei Yuan
Journal:  Sci Rep       Date:  2015-12-22       Impact factor: 4.379

4.  The Mechanisms Underlying the Protective Action of Selenium Nanoparticles against Ischemia/Reoxygenation Are Mediated by the Activation of the Ca2+ Signaling System of Astrocytes and Reactive Astrogliosis.

Authors:  Elena G Varlamova; Egor A Turovsky; Valentina A Babenko; Egor Y Plotnikov
Journal:  Int J Mol Sci       Date:  2021-11-26       Impact factor: 5.923

Review 5.  The potential role of DNA methylation as preventive treatment target of epileptogenesis.

Authors:  Toni Christoph Berger; Erik Taubøll; Kjell Heuser
Journal:  Front Cell Neurosci       Date:  2022-07-22       Impact factor: 6.147

Review 6.  Events Occurring in the Axotomized Facial Nucleus.

Authors:  Kazuyuki Nakajima; Takashi Ishijima
Journal:  Cells       Date:  2022-06-29       Impact factor: 7.666

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.